{
    "id": 5106,
    "fullName": "RET C634F",
    "impact": "missense",
    "proteinEffect": "gain of function - predicted",
    "geneVariantDescriptions": [
        {
            "description": "RET C634F lies within the cysteine-rich region of the Ret protein (PMID: 9879991). C634F has not been fully biochemically characterized, but is transforming in cell culture (PMID: 9230192), thus is predicted to confer a gain of function on the Ret protein.",
            "references": [
                {
                    "id": 2271,
                    "pubMedId": 9879991,
                    "title": "Dual effect on the RET receptor of MEN 2 mutations affecting specific extracytoplasmic cysteines.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/9879991"
                },
                {
                    "id": 2272,
                    "pubMedId": 9230192,
                    "title": "Biological properties of Ret with cysteine mutations correlate with multiple endocrine neoplasia type 2A, familial medullary thyroid carcinoma, and Hirschsprung's disease phenotype.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/9230192"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 5979,
        "geneSymbol": "RET",
        "terms": [
            "RET",
            "CDHF12",
            "CDHR16",
            "HSCR1",
            "MEN2A",
            "MEN2B",
            "MTC1",
            "PTC",
            "RET-ELE1"
        ]
    },
    "variant": "C634F",
    "createDate": "04/21/2015",
    "updateDate": "10/22/2018",
    "referenceTranscriptCoordinates": {
        "id": 125227,
        "transcript": "NM_020975",
        "gDna": "chr10:g.43114501G>T",
        "cDna": "c.1901G>T",
        "protein": "p.C634F",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 10454,
            "approvalStatus": "Phase II",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a Phase II trial, Nexavar (sorafenib) treatment resulted in stable disease in one patient with medullary thyroid carcinoma harboring RET C634F (PMID: 20368568).",
            "molecularProfile": {
                "id": 4919,
                "profileName": "RET C634F"
            },
            "therapy": {
                "id": 920,
                "therapyName": "Sorafenib",
                "synonyms": null
            },
            "indication": {
                "id": 3973,
                "name": "thyroid gland medullary carcinoma",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 8463,
                    "pubMedId": 20368568,
                    "title": "Phase II clinical trial of sorafenib in metastatic medullary thyroid cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/20368568"
                }
            ],
            "ampCapAscoEvidenceLevel": "B",
            "ampCapAscoInferredTier": "I"
        }
    ],
    "molecularProfiles": [
        {
            "id": 4919,
            "profileName": "RET C634F",
            "profileTreatmentApproaches": [
                {
                    "id": 3904,
                    "name": "RET Inhibitor",
                    "profileName": "RET C634F"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 125227,
            "transcript": "NM_020975",
            "gDna": "chr10:g.43114501G>T",
            "cDna": "c.1901G>T",
            "protein": "p.C634F",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 125228,
            "transcript": "NM_020630",
            "gDna": "chr10:g.43114501G>T",
            "cDna": "c.1901G>T",
            "protein": "p.C634F",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}